Exo360 wins Innobooster grant

Share:
Exo360 wins Innobooster grant
Exo360 are close to getting their Exocast Wrist on patients to improve the treatment of wrist fractures.

 

The team has been working tirelessly and expanding progressively, since Mads Terndrup got the idea to replace traditional plaster casts with their adaptive meta-materials. They are now getting close to their goal, and expect to perform clinical tests later this year, with the hope of getting their CE mark by the end of the year.
The Innobooster grant of DKK2,1M will assist them in the last stages and allow them to reach the finishline.

 

“We are incredibly grateful to Innovationsfonden for their support over the years. Their backing through the Innofounder programme helped us define our company, and the previous Innobooster grant enabled us to validate our thesis. This latest funding will provide the final push we need to bring our product to market, allowing us to truly make a difference in patients’ lives.” – Mads Terndrup, CEO.

Traditional plaster casts, while reliable, have a significant drawback: A freshly broken limb swells up, and this is when the plaster cast is applied. But, as part of the healing process, the swelling also goes down again. When that happens and the static cast doesn’t follow the limb, it is no longer stabile inside the cast. This instability can lead to re-injury and surgery in 1 out of 3 wrist fracture cases.

The Exo360 Wrist addresses this issue by holding the limb securely in the correct position while applying even pressure, while swelling decreases.

 

Interested in getting an investment from Accelerace? We are industry agnostic and invest in pre-seed stage startups based in the Nordics and Baltics. Submit your pitch deck here! If you like being prepared and want to know how likely your startup is to get an investment from us beforehand, take our investment readiness test here!Get the secrets to product market fit and raising funding, FOR FREE

About Accelerace:

Since 2008, Accelerace has supported 1000+ Danish and international startups, including Trustpilot and Templafy, through our accelerator program, made 200+ pre-seed investments and matched startups with industry-leading companies such as Tetra Pak, Arla, and Elia. Accelerace is also responsible for the management of NOME (Nordic Mentor Network for Entrepreneurship), an elite mentoring program for Nordic life science startups.

Accelerace Invest II is the largest Danish fund in terms of the number of investments. By making approximately 30 new investments/year in pre-seed startups based in the Nordics and Baltics, the ambition is to be Denmark’s most aggressive early-stage investor.

Previous post
New investment used by clubs from Premier League and Champions League
Next post
Accelerace invests in cultivated meat technology